3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
5
Carcinoma, Non-Small-Cell Lung
3
Breast Neoplasms
3
Triple Negative Breast Neoplasms
2
Colonic Neoplasms
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tooth, Impacted
1
Testicular Neoplasms
1
Smoldering Multiple Myeloma
1
Oropharyngeal Neoplasms
1
Neuroblastoma
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Melanoma
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
Hepatoblastoma
1
Hematologic Neoplasms
1
Hemangioma, Cavernous, Central Nervous System
1
Hemangioma, Cavernous
1
Ganglioneuroblastoma
1
Fibrolamellar hepatocellular carcinoma
1
Esophageal Neoplasms
1
Epstein-Barr Virus Infections
1
Carcinoma, Renal Cell
1
Breast Carcinoma In Situ
1
Anus Neoplasms
1
Anal Canal Carcinoma
1
Interventions
Carboplatin
3
Cisplatin
2
veliparib
1
Watchful Waiting
1
Tomography, X-Ray Computed
1
Taxes
1
Psychiatric Nursing
1
Physical Therapy Modalities
1
Paclitaxel
1
Magnetic Resonance Spectroscopy
1
Fluorodeoxyglucose F18
1
FAPI-46
1
Etoposide
1
Educational Status
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Testicular Neoplasms
×
Watchful Waiting
×
Clear all
NCT04848545
2021-04-21
DISRUPT
Rigshospitalet, Denmark
Active not recruiting
700 enrolled